These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1647576)

  • 1. Genetically-engineered subunit vaccine against feline leukaemia virus: protective immune response in cats.
    Marciani DJ; Kensil CR; Beltz GA; Hung CH; Cronier J; Aubert A
    Vaccine; 1991 Feb; 9(2):89-96. PubMed ID: 1647576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a genetically engineered vaccine against feline leukemia virus infection.
    Kensil CR; Barrett C; Kushner N; Beltz G; Storey J; Patel U; Recchia J; Aubert A; Marciani D
    J Am Vet Med Assoc; 1991 Nov; 199(10):1423-7. PubMed ID: 1666096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene.
    Weijer K; Pfauth A; van Herwijnen R; Jarrett O; Meloen RH; Tomee C; Osterhaus AD
    Vaccine; 1993; 11(9):946-56. PubMed ID: 7692683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.
    Langhammer S; Hübner J; Kurth R; Denner J
    Immunology; 2006 Feb; 117(2):229-37. PubMed ID: 16423059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of protective immune response in cats by vaccination with feline leukemia virus iscom.
    Osterhaus A; Weijer K; Uytdehaag F; Jarrett O; Sundquist B; Morein B
    J Immunol; 1985 Jul; 135(1):591-6. PubMed ID: 2987351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
    Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
    J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety field trials of a recombinant DNA vaccine against feline leukemia virus infection.
    Clark N; Kushner NN; Barrett CB; Kensil CR; Salsbury D; Cotter S
    J Am Vet Med Assoc; 1991 Nov; 199(10):1433-43. PubMed ID: 1666099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No benefit of therapeutic vaccination in clinically healthy cats persistently infected with feline leukemia virus.
    Helfer-Hungerbuehler AK; Spiri AM; Riond B; Grest P; Boretti FS; Hofmann-Lehmann R
    Vaccine; 2015 Mar; 33(13):1578-85. PubMed ID: 25698488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
    Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
    J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A targeted mutation within the feline leukemia virus (FeLV) envelope protein immunosuppressive domain to improve a canarypox virus-vectored FeLV vaccine.
    Schlecht-Louf G; Mangeney M; El-Garch H; Lacombe V; Poulet H; Heidmann T
    J Virol; 2014 Jan; 88(2):992-1001. PubMed ID: 24198407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a subunit feline leukemia virus vaccine in exotic cats.
    Citino SB
    J Am Vet Med Assoc; 1988 Apr; 192(7):957-9. PubMed ID: 2835347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vector expressing feline mature IL-18 fused to IL-1beta antagonist protein signal sequence is an effective adjuvant to a DNA vaccine for feline leukaemia virus.
    O'Donovan LH; McMonagle EL; Taylor S; Bain D; Pacitti AM; Golder MC; McDonald M; Hanlon L; Onions DE; Argyle DJ; Jarrett O; Nicolson L
    Vaccine; 2005 May; 23(29):3814-23. PubMed ID: 15893619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of feline leukaemia virus.
    Weijer K; Uytdehaag FG; Osterhaus AD
    Vet Immunol Immunopathol; 1989 May; 21(1):69-83. PubMed ID: 2549695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feline leukemia virus envelope protein expression encoded by a recombinant vaccinia virus: apparent lack of immunogenicity in vaccinated animals.
    Gilbert JH; Pedersen NC; Nunberg JH
    Virus Res; 1987 Feb; 7(1):49-67. PubMed ID: 3031895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination of cats against infection with feline leukemia virus (FeLV): first recombinant vaccine and the effect of a pre-existing infection with feline immunodeficiency virus (FIV)].
    Hofmann-Lehmann R; Aubert A; Wolfensberger C; Cronier J; Lutz H
    Schweiz Arch Tierheilkd; 1994; 136(10):340-51. PubMed ID: 7801087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
    Grosenbaugh DA; Leard T; Pardo MC
    J Am Vet Med Assoc; 2006 Mar; 228(5):726-7. PubMed ID: 16506935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of immunosuppressive effect and efficacy of an improved-potency feline leukaemia vaccine.
    Haffer KN; Koertje WD; Derr JT; Beckenhauer WH
    Vaccine; 1990 Feb; 8(1):12-6. PubMed ID: 2156386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of cats against feline leukemia virus by vaccination with a canarypox virus recombinant, ALVAC-FL.
    Tartaglia J; Jarrett O; Neil JC; Desmettre P; Paoletti E
    J Virol; 1993 Apr; 67(4):2370-5. PubMed ID: 8383248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of diethylcarbamazine on cats given feline leukaemia virus vaccine.
    Kitchen LW
    Vaccine; 1987 Dec; 5(4):266-7. PubMed ID: 2829454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against oronasal challenge with virulent feline leukaemia virus lasts for at least 12 months following a primary course of immunisation with Leukocell 2 vaccine.
    Harbour DA; Gunn-Moore DA; Gruffydd-Jones TJ; Caney SM; Bradshaw J; Jarrett O; Wiseman A
    Vaccine; 2002 Jul; 20(23-24):2866-72. PubMed ID: 12126896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.